Literature DB >> 27142514

An uncommon and insidious presentation of renal cell carcinoma with tumor extending into the inferior vena cava and right atrium: a case report.

Hou Tee Lu1,2, Jen Lim Chong3, Norliza Othman4, Simon Vendargon5, Shamsuddin Omar6.   

Abstract

BACKGROUND: Renal cell carcinoma is a potentially lethal cancer with aggressive behavior and it tends to metastasize. Renal cell carcinoma involves the inferior vena cava in approximately 15% of cases and it rarely extends into the right atrium. A majority of renal cell carcinoma are detected as incidental findings on imaging studies obtained for unrelated reasons. At presentation, nearly 25% of patients either have distant metastases or significant local-regional disease with no symptoms that can be attributed to renal cell carcinoma. CASE
PRESENTATION: A 64-year-old Indian male with a past history of coronary artery bypass graft surgery, congestive heart failure, and diabetes mellitus complained of worsening shortness of breath for 2 weeks. Incidentally, a transthoracic echocardiography showed a "thumb-like" mass in his right atrium extending into his right ventricle through the tricuspid valve with each systole. Abdomen magnetic resonance imaging revealed a heterogenous lobulated mass in the upper and mid-pole of his right kidney with a tumor extending into his inferior vena cava and right atrium, consistent with our diagnosis of advanced renal cell carcinoma which was later confirmed by surgical excision and histology. Radical right nephrectomy, lymph nodes clearance, inferior vena cava cavatomy, and complete tumor thrombectomy were performed successfully. Perioperatively, he did not require cardiopulmonary bypass or deep hypothermic circulatory arrest. He had no recurrence during the follow-up period for more than 2 years after surgery.
CONCLUSIONS: Advanced extension of renal cell carcinoma can occur with no apparent symptoms and be detected incidentally. In rare circumstances, atypical presentation of renal cell carcinoma should be considered in a patient presenting with right atrial mass detected by echocardiography. Renal cell carcinoma with inferior vena cava and right atrium extension is a complex surgical challenge, but excellent results can be obtained with proper patient selection, meticulous surgical techniques, and close perioperative patient care.

Entities:  

Keywords:  Renal cell carcinoma; Right atrial mass; Thrombus

Mesh:

Year:  2016        PMID: 27142514      PMCID: PMC4855703          DOI: 10.1186/s13256-016-0888-5

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Background

Renal cell carcinoma (RCC) is a potentially lethal cancer with aggressive behavior and it tends to metastasize. RCC may present atypically with rare metastatic sites [1, 2]. Intravascular tumor growth along the renal vein into the inferior vena cava (IVC) occurs in up to 15 % of all patients with RCC and further extension of the tumor reaching the right atrium (RA) will be found in approximately 1 % of all patients [3].

Case presentation

In a routine clinic follow-up, a 64-year-old Indian male with a past history of coronary artery bypass graft (CABG) surgery, congestive heart failure, and diabetes mellitus complained of worsening shortness of breath for 2 weeks. He reported normal urination and had no fever or weight loss. He had no past history or family history of cancer. On examination, he was obese (BMI 38 kg/m2), his radial pulse was regular (95/minute), afebrile, and his blood pressure was 110/70 mmHg. Cardiovascular examinations revealed a mid-line sternotomy scar, displaced apex beat, and diminution of heart sounds with no murmur. Fine crepitations were heard in his lung bases bilaterally. His liver and spleen were not enlarged. The results of the remainder of his examinations were normal. His laboratory results were as follows: hemoglobin, 13 g/dl; leukocyte count, 7.4×109/L; platelet count, 159×109/L; serum creatinine, 90 μmol/L; alanine aminotransferase (ALT), 15 IU/L; and urinalysis revealed plenty of microscopic red blood cells. His chest X-ray showed cardiomegaly and his ECG showed sinus rhythm with nonspecific T inversion at lateral leads. Transthoracic echocardiography (TTE) showed impaired left ventricular systolic function with ejection fraction of 40 %, and a large, highly mobile, “thumb-like” mass in the RA extending into right ventricle through the tricuspid valve with each systole (Fig. 1; see Additional files 1 and 2). His tricuspid valve function was normal. Abdomen magnetic resonance imaging (MRI) revealed a heterogenous lobulated mass (measuring 6.8×8.4×4.2 cm) in the upper and mid-pole of his right kidney suggestive of right RCC, with tumor thrombus extended into his IVC (infrahepatic, intrahepatic, and suprahepatic) and RA (Figs. 2 and 3). The imaging findings were consistent with a diagnosis of RCC level IV, classified according to the upper margin of the tumor in his IVC [4]. The diagnosis of RCC (clear cell type), Fuhrman grade 2, measuring 200×50×60 mm of total tumor size was confirmed later by histopathologic examination of the surgical specimens. Abdominal and thorax computed tomography (CT) was done for the purpose of tumor staging. Similar findings were found on CT scan with no evidence of distant metastasis. He was hospitalized for anticoagulation and heart failure therapy. Angiographic CABG conduits were assessed prior to surgery. Native coronary vessels were diffusely diseased. His left internal mammary artery graft and saphenous venous grafts were collectively normal. Subsequently, he underwent right nephrectomy, cavatomy, and thrombectomy successfully. The imaging findings were confirmed on surgical excision and histology. Findings from the nephrectomy specimen showed that the tumor was protruding from his renal vein and extended to the superior pole of his kidney. Grossly, the outer surface of his kidney was fairly smooth and lobulated and had not breached the renal capsule. Histopathologic examination showed the malignant cells were mainly clear cytoplasm with a distinct cell membrane; they exhibited fairly uniform, round, slightly irregular, vesicular nuclei with small nucleoli. The tumor infiltrated the renal parenchyma and extended into his renal capsule but did not invade his perirenal fat or Gerota’s fascia. The tumor extended into his renal pelvis and his dilated renal vein, and it adhered to the vessel wall. Finally, there was no evidence of recurrence (confirmed by repeat abdomen MRI and TTE) during the follow-up period for more than 2 years after surgery at our out-patient clinic.
Fig. 1

Apical four-chamber (a) and subcostal (b) views by transthoracic echocardiography showing the large mobile mass (white arrow) from inferior vena cava moving into right atrium and right ventricle

Fig. 2

Axial T2-weighted fat saturation (a) and balanced turbo field echo (b) images showing the heterogenous right renal mass with cystic component (arrow) and formation of tumor thrombus in the dilated right renal vein (yellow asterisk) which protrudes into the intrahepatic inferior vena cava (white triangle)

Fig. 3

Coronal balanced turbo field echo images showing right renal mass (yellow asterisk) (a) with tumor thrombus in the engorged right renal vein (white triangle) extends cranially into the intrahepatic and suprahepatic inferior vena cava (white arrow) encroaching into the right atrium (b)

Apical four-chamber (a) and subcostal (b) views by transthoracic echocardiography showing the large mobile mass (white arrow) from inferior vena cava moving into right atrium and right ventricle Axial T2-weighted fat saturation (a) and balanced turbo field echo (b) images showing the heterogenous right renal mass with cystic component (arrow) and formation of tumor thrombus in the dilated right renal vein (yellow asterisk) which protrudes into the intrahepatic inferior vena cava (white triangle) Coronal balanced turbo field echo images showing right renal mass (yellow asterisk) (a) with tumor thrombus in the engorged right renal vein (white triangle) extends cranially into the intrahepatic and suprahepatic inferior vena cava (white arrow) encroaching into the right atrium (b)

Discussion

We reported a case of RCC with insidious presentation detected incidentally. The clinical course of our patient was subtle. He did not present with the classical triad of hematuria, flank pain, or flank mass, and had no apparent symptoms despite extension of the tumor thrombus into his IVC and RA. The diagnosis of RCC was considered after accidental detection of his RA mass by TTE. Common differential diagnoses of right atrial mass include thrombus (pulmonary emboli), cardiac tumors (primary or metastatic), and tricuspid valve vegetations, whereas uncommon differential diagnoses of right atrial mass include anatomic variants, coronary fistula, indwelling catheter, and pacer wires. With the more liberal use of radiological imaging techniques in current practice, the incidental finding of right atrial mass is particularly important for cardiologists, radiologists, or sonographers and the diagnosis of RCC should always be taken into consideration. A similar presentation of RCC extension into RA had been reported earlier in a series of case reports [3, 5, 6]. The majority (>70 %) of RCC are detected as incidental findings on imaging studies obtained for unrelated reasons [7]. At presentation, nearly 25 % of patients either have distant metastases or significant local-regional disease with no symptoms that can be attributed to renal cell carcinoma. One of the striking characteristics of RCC is its tendency to invade the renal vein, in which it may grow as a solid column of cells that extends up the IVC, sometimes as far as the right side of the heart [8]. Surgical treatment in patients with RCC extending into RA is challenging and controversy still exists regarding the safest strategy. The radical surgical strategy may include extracorporeal circulation with cardiopulmonary bypass (CPB) and sometimes deep hypothermic circulatory arrest (DHCA) [3]. Long-term survival is possible and the operative approach has been described earlier [4, 9]. For our patient, care was taken perioperatively since the surgical approach was complex and our patient had a past history of CABG. Fortunately, radical right nephrectomy, lymph nodes clearance, IVC cavatomy, and complete tumor thrombectomy (Fig. 4) were accomplished by a urologist in collaboration with a cardiothoracic surgeon. Although we considered CPB and DHCA in our preoperative plan, our patient did not require them. The reason was that he had a previous CABG which may have complicated the surgery. Furthermore, based on MRI findings the tumor thrombus in his IVC and RA did not adhere to adjacent structures. During surgical exploration, the surgeons managed to extract the tumor thrombus en bloc via the division of his right renal vein to his IVC. Histological analysis confirmed the diagnosis of clear cell type, the most common subtype of RCC, Fuhrman grade 2.
Fig. 4

Surgically excised right renal tumor, cavatomy, and complete tumor thrombectomy

Surgically excised right renal tumor, cavatomy, and complete tumor thrombectomy

Conclusions

Advanced extension of RCC can occur with no apparent symptoms and be detected incidentally. In rare circumstances, atypical presentation of RCC should be considered in a patient presenting with right atrial mass detected by echocardiography. RCC with IVC and RA extension is a complex surgical challenge, but excellent results can be obtained with proper patient selection, meticulous surgical techniques and close perioperative patient care.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
  7 in total

1.  Surgical treatment of renal cell carcinoma with intravascular extension.

Authors:  Christoph Schimmer; Felix Hillig; Hubertus Riedmiller; Olaf Elert
Journal:  Interact Cardiovasc Thorac Surg       Date:  2004-06

2.  Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.

Authors:  J C Nesbitt; E R Soltero; C P Dinney; G L Walsh; D S Schrump; D A Swanson; L L Pisters; K D Willis; J B Putnam
Journal:  Ann Thorac Surg       Date:  1997-06       Impact factor: 4.330

Review 3.  Evaluation and management of the renal mass.

Authors:  David Y T Chen; Robert G Uzzo
Journal:  Med Clin North Am       Date:  2011-01       Impact factor: 5.456

4.  Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.

Authors:  Jan Dominik; Petr Moravek; Pavel Zacek; Jan Vojacek; Miroslav Brtko; Miroslav Podhola; Jaroslav Pacovsky; Jan Harrer
Journal:  BJU Int       Date:  2012-09-18       Impact factor: 5.588

5.  Management of renal cell carcinoma with intracardiac extension.

Authors:  Hakan Posacioglu; Mehmet Fatih Ayik; Murat Zeytunlu; Dilsad Amanvermez; Cagatay Engin; Anil Ziya Apaydin
Journal:  J Card Surg       Date:  2008 Nov-Dec       Impact factor: 1.620

6.  Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports.

Authors:  Petros Sountoulides; Linda Metaxa; Luca Cindolo
Journal:  J Med Case Rep       Date:  2011-09-02

7.  Atypical presentation of renal cell carcinoma: a case report.

Authors:  Deepak Doshi; Michael Saab; Nidhi Singh
Journal:  J Med Case Rep       Date:  2007-06-06
  7 in total
  3 in total

1.  Ball-shaped right atrial mass in renal cell carcinoma: A case report.

Authors:  Sohil Pothiawala; Savan deSilva; Kunzang Norbu
Journal:  World J Crit Care Med       Date:  2022-03-15

2.  Metastatic renal cell carcinoma complicated by right atrial thrombus.

Authors:  Hafiz Muhammad Abrar Jeelani; Muhammad Mubbashir Sheikh; Adeel Riaz; Nikita Jain; Nayha Tahir; Hamid Ehsan; Lalitha Vemireddy
Journal:  Clin Case Rep       Date:  2021-03-11

3.  Atrial Metastasis of Renal Cell Carcinoma: A Rare Presentation.

Authors:  Shilpi Shah; Poornima Vinod; Mohamed Khayata; Jason L Lane; Vinayak Hegde; Rupesh Raina
Journal:  Cardiol Res       Date:  2018-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.